These are the same general criteria used in the approved indication for Wegovy and in the FDA labeling for GLP-1 drugs for cardiovascular risk reduction
Self-dosing from online figures skips every one of those safeguards, and in a medical context those safeguards are the entire point
Your healthcare team can recommend specific tests to track your progress and interpret results to understand how your weight loss journey affects different aspects of your health.
Overall, Zepbound may lead to more weight loss on average, but individual results vary, and the Wegovy HD option narrows the gap
Peak weight loss ~15.6% Price $45.00 GLP2-T Adds GIP receptor agonism on top of GLP-1 3050% greater weight loss than single-agonist GLP-1 at comparable dosing
Typically, however, semaglutide GLP-1 is meant for obese patients and the general rule of thumb is that its intended for patients with a body mass index (BMI) of 27kg/m2 or higher and/or another condition related to being overweight